Skip to main content
Study

Medication safety in the ambulatory chemotherapy setting.

Gandhi TK, Bartel SB, Shulman LN, et al. Medication safety in the ambulatory chemotherapy setting. Cancer. 2005;104(11). doi:10.1002/cncr.21442.

Save
Print
November 9, 2005
Gandhi TK, Bartel SB, Shulman LN, et al. Cancer. 2005;104(11).

Chemotherapeutic drugs share the characteristic of providing life-saving benefits at the expense of substantial toxicity if not administered and monitored carefully. With ongoing advances in such therapy and a growing shift to outpatient treatment in infusion clinics, this prospective cohort study evaluated more than 10,000 medication orders at a cancer institute in both adult and pediatric settings. Investigators discovered an overall error rate of 3%, with the majority of errors deemed to have a potential for harm. Most of the errors never reached the patient as nurses and pharmacists caught them before administration. Of note, the reported error rate of 3% was lower than past studies in inpatient (5%) and outpatient settings (8%). The authors conclude by sharing the prevention strategies that came from their local findings and how the complexity of outpatient oncology treatment warrants ongoing attention.

Save
Print
Cite
Citation

Gandhi TK, Bartel SB, Shulman LN, et al. Medication safety in the ambulatory chemotherapy setting. Cancer. 2005;104(11). doi:10.1002/cncr.21442.